A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance

Simple item page
dc.article.number7238
dc.catalogadorjca
dc.contributor.authorVergara-Gómez, Luis
dc.contributor.authorBizama, Carolina
dc.contributor.authorZhong, Jun
dc.contributor.authorBuchegger, Kurt
dc.contributor.authorSuárez Vega, Felipe Ignacio
dc.contributor.authorRosa, Lorena
dc.contributor.authorIli, Carmen
dc.contributor.authorWeber, Helga
dc.contributor.authorObreque, Javiera
dc.contributor.authorEspinoza, Karena
dc.contributor.authorRepetto, Gabriela
dc.contributor.authorRoa, Juan C.
dc.contributor.authorLeal, Pamela
dc.contributor.authorGarcía, PatriciaVergara-Gómez, Luis
dc.contributor.authorBizama, Carolina
dc.contributor.authorZhong, Jun
dc.contributor.authorBuchegger, Kurt
dc.contributor.authorSuárez Vega, Felipe Ignacio
dc.contributor.authorRosa, Lorena
dc.contributor.authorIli, Carmen
dc.contributor.authorWeber, Helga
dc.contributor.authorObreque, Javiera
dc.contributor.authorEspinoza, Karena
dc.contributor.authorRepetto, Gabriela
dc.contributor.authorRoa, Juan C.
dc.contributor.authorLeal, Pamela
dc.contributor.authorGarcía, Patricia
dc.date.accessioned2023-05-12T15:36:57Z
dc.date.available2023-05-12T15:36:57Z
dc.date.issued2023
dc.description.abstractTreatment options for advanced gallbladder cancer (GBC) are scarce and usually rely on cytotoxic chemotherapy, but the effectiveness of any regimen is limited and recurrence rates are high. Here, we investigated the molecular mechanisms of acquired resistance in GBC through the development and characterization of two gemcitabine-resistant GBC cell sublines (NOZ GemR and TGBC1 GemR). Morphological changes, cross-resistance, and migratory/invasive capabilities were evaluated. Then, microarray-based transcriptome profiling and quantitative SILAC-based phosphotyrosine proteomic analyses were performed to identify biological processes and signaling pathways dysregulated in gemcitabine-resistant GBC cells. The transcriptome profiling of parental and gemcitabine-resistant cells revealed the dysregulation of protein-coding genes that promote the enrichment of biological processes such as epithelial-to-mesenchymal transition and drug metabolism. On the other hand, the phosphoproteomics analysis of NOZ GemR identified aberrantly dysregulated signaling pathways in resistant cells as well as active kinases, such as ABL1, PDGFRA, and LYN, which could be novel therapeutic targets in GBC. Accordingly, NOZ GemR showed increased sensitivity toward the multikinase inhibitor dasatinib compared to parental cells. Our study describes transcriptome changes and altered signaling pathways occurring in gemcitabine-resistant GBC cells, which greatly expands our understanding of the underlying mechanisms of acquired drug resistance in GBC.
dc.fechaingreso.objetodigital2023-05-12
dc.fuente.origenORCID
dc.identifier.doi10.3390/ijms24087238
dc.identifier.issn1422-0067
dc.identifier.urihttps://doi.org/10.3390/ijms24087238
dc.identifier.urihttps://www.mdpi.com/1422-0067/24/8/7238
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/66962
dc.information.autorucEscuela de Medicina;Bizama, Carolina;0000-0002-5379-6191;237745
dc.information.autorucFacultad de Agronomía e Ingenieria Forestal;Suárez Vega, Felipe Ignacio;S/I;215358
dc.information.autorucEscuela de Medicina;Obreque, Javiera;S/I;1025200
dc.information.autorucEscuela de Medicina;Roa, Juan C.;0000-0001-8313-8774;84743
dc.issue.numero8
dc.language.isoen
dc.nota.accesoContenido completo
dc.pagina.final17
dc.pagina.inicio1
dc.revistaInternational Journal of Molecular Sciences
dc.rightsacceso abierto
dc.subjectGallbladder cancer
dc.subjectAcquired drug resistance
dc.subjectGemcitabine
dc.subjectEpithelial-to-mesenchymal transition
dc.subjectGene expression profiling
dc.subjectSILAC-based phosphoproteomics
dc.subjectCytidine deaminase
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.titleA Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance
dc.typeartículo
dc.volumen24
sipa.codpersvinculados237745
sipa.codpersvinculados215358
sipa.codpersvinculados1025200
sipa.codpersvinculados84743
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
4_novel_gemcitabine.pdf
Size:
2.58 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas